Overview
- 5 inspections across 5 sites are on record.
- 5 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-05.
At a glance
Inspections
5
Sites
5
Observations
5
Career since
Sep 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Grifols Therapeutics LLC | 5 Feb 2026 | Biologics | View 483 → |
| Lonza Biologics, Inc. | 7 Mar 2024 | Biologics | On file |
| Grifols Biologicals LLC | 12 Sep 2019 | Biologics | On file |
| Grifols Biologicals LLC | 12 Sep 2019 | Biologics | On file |
| Bayer HealthCare LLC | 21 Sep 2018 | Biologics | On file |
Sites inspected
Grifols Therapeutics LLCClayton, United States1 insp.
Lonza Biologics, Inc.Portsmouth, United States1 insp.
Grifols Biologicals LLCCity Of Industry, United States1 insp.
Grifols Biologicals LLCLos Angeles, United States1 insp.
Bayer HealthCare LLCBerkeley, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Omotunde O Osunsanmi3 shared
Nobuko H Katagiri2 shared
Olga Simakova2 shared
Decarlos A Gomez2 shared
Katarzyna I Jankowska1 shared
Brentley S Pittman1 shared
Jennifer L Reed1 shared
Svetlana A Shestopal1 shared
Priscilla M Pastrana1 shared
Lewis K Antwi1 shared
Full investigator report
Get the verbatim findings behind Vijaya L Simhadri's 5 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site